Markets Gone Wild

Amends Revolving Credit Agreement to Accommodate the Acquisition PITTSBURGH, Aug. 12, 2022 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR “L.B. Foster”), a global solutions provider of products and services for the rail and infrastructure markets, today announced that its wholly-owned subsidiary, CXT Incorporated (“CXT”) (L.B. Foster and CXT are sometimes collectively referred to as…

OLO Shareholder News: Johnson Fistel Encourages Olo Shareholders with Losses to Contact the Firm Investigation into Potential Securities Laws Violations SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating whether Olo Inc. (“Olo” or the “Company”), any of its executive officers, or others violated securities laws by…

Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update PCS12852 on target to complete enrollment by September Expanded efforts to increase enrollment in PCS499 and PCS6422 showing results Exciting news for Processa Pharmaceuticals, Inc. as they announce their second quarter 2022 financial results and provide a corporate update. With PCS12852 on track…

Navios Maritime Holdings Inc. Announces Satisfaction and Discharge of Indenture Governing 11.25% Senior Secured Notes GRAND CAYMAN, Cayman Islands, Aug. 12, 2022 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE: NM), a global seaborne shipping and logistics company, announced today that on August 11, 2022, the Company satisfied and discharged…

VYNE Therapeutics Reports Second Quarter 2022 Financial Results Bridgewater, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced financial results for the three and six months ended June 30, 2022. During…

Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes What is Cerevel Therapeutics? Cerevel Therapeutics Holdings, Inc. is a company based in Cambridge, Massachusetts that is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. Their mission is to develop innovative treatments for conditions that affect the brain…

The Influence of Brent Donnelly’s am/FX Introduction Brent Donnelly’s am/FX is a highly regarded resource in the global markets community, providing valuable insights on a daily basis. His in-depth analysis on various topics related to global markets has gained him a loyal following among traders and investors. What am/FX Covers Brent covers a wide range…

MetaFi: The Future of Finance? A Conversation with Vladmir Gorbunov From CeFi to DeFi: The Evolution of Choise.com Welcome, readers, to another exciting installment of Finance Magnates interviews! Today, we have the pleasure of sitting down with Vladimir Gorbunov, the dynamic CEO of Choise.com. If you’re not familiar with Choise.com, let me break it down…